NYSE · Medical - Healthcare Plans
OSCR (OSCR) Stock
$30.98
-1.34%
NYSE: OSCR
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
5 Insurance Stocks Poised to Outperform Q2 Earnings Expectations
Zacks · Jul 22, 2026
Oscar Health, Inc. (OSCR) Is a Trending Stock: Facts to Know Before Betting on It
Zacks · Jul 17, 2026
Why Fast-paced Mover Oscar Health (OSCR) Is a Great Choice for Value Investors
Zacks · Jul 16, 2026
1 Russell 2000 Stock to Own for Decades and 2 We Avoid
StockStory · Jul 16, 2026
Zacks Industry Outlook Highlights Oscar Health, Radian, CNO Financial, Pelagos Insurance Capital and Horace Mann Educators
Zacks · Jul 16, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held5.38%
Institutions Held67.61%
Institutions Float Held71.45%
Peer Comparison
About OSCR
OSCR is led by CEO Mark Thomas Bertolini, employs 2,305 people, headquartered in New York City, US, publicly traded since 2021.
OSCR stock trades at $30.98 with a market capitalization of $8.03B. The stock is valued at a price-to-earnings (P/E) ratio of -14.51, price-to-book of 6.50, price-to-sales of 0.48. Over the past 52 weeks the stock has ranged between $10.69 and $33.02, and currently trades 6.2% below its 52-week high.
On profitability, OSCR generates a return on equity (ROE) of -45.30%, return on capital employed of -40.41%, an operating margin of -3.38%, a net profit margin of -0.30%.